Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Camp4 Therapeutics Corp (CAMP)

Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 104,837
  • Shares Outstanding, K 20,161
  • Annual Sales, $ 294,950 K
  • Annual Income, $ -32,490 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $-24.19 on 11/21/24
  • Next Earnings Date 07/08/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.82
  • Number of Estimates 4
  • High Estimate -0.55
  • Low Estimate -1.22
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.06 +34.23%
on 11/25/24
10.80 -49.54%
on 12/05/24
+0.04 (+0.74%)
since 11/22/24

Most Recent Stories

More News
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors

CAMP : 5.59 (+7.50%)
CAMP4 Therapeutics to Present at Piper Sandler 36th Annual Healthcare Conference

CAMP4 Therapeutics will present at the Piper Sandler Healthcare Conference on December 5, 2024, in New York City.Quiver AI SummaryCAMP4 Therapeutics Corporation, a clinical-stage biotechnology firm focused...

CAMP : 5.59 (+7.50%)
CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference

CAMP : 5.59 (+7.50%)
CAMP4 Therapeutics Completes $82.1M IPO and Enters $370M Collaboration with BioMarin

CAMP4 Therapeutics completed a $82.1M IPO, finished Phase 1 SAD for CMP-CPS-001, and partnered with BioMarin on research.Quiver AI SummaryCAMP4 Therapeutics Corporation announced the successful completion...

CAMP : 5.59 (+7.50%)
CAMP4 Reports Third Quarter 2024 Financial Results

CAMP : 5.59 (+7.50%)
CAMP4 Announces Pricing of Initial Public Offering

CAMP : 5.59 (+7.50%)
CalAmp: Fiscal Q3 Earnings Snapshot

CalAmp: Fiscal Q3 Earnings Snapshot

CAMP : 5.59 (+7.50%)
CalAmp, Levi Strauss fall; Pioneer Natural, NuScale rise Friday, 10/6/2023

Stocks that traded heavily or had substantial price changes on Friday: CalAmp, Levi Strauss fall; Pioneer Natural, NuScale rise

CAMP : 5.59 (+7.50%)
NEM : 37.59 (-1.80%)
BLKB : 75.87 (-0.58%)
LEVI : 17.24 (-0.86%)
PXD : 269.62 (+0.73%)
FCX : 38.79 (-0.18%)
XOM : 105.17 (-0.66%)
CalAmp: Fiscal Q2 Earnings Snapshot

CalAmp: Fiscal Q2 Earnings Snapshot

CAMP : 5.59 (+7.50%)
CalAmp: Fiscal Q1 Earnings Snapshot

CalAmp: Fiscal Q1 Earnings Snapshot

CAMP : 5.59 (+7.50%)

Business Summary

CAMP4 Therapeutics Corporation is a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases. CAMP4 Therapeutics Corporation is based...

See More

Key Turning Points

3rd Resistance Point 7.84
2nd Resistance Point 7.07
1st Resistance Point 6.14
Last Price 5.59
1st Support Level 4.44
2nd Support Level 3.67
3rd Support Level 2.74

See More

52-Week High 12.30
Fibonacci 61.8% 9.15
Fibonacci 50% 8.18
Fibonacci 38.2% 7.21
Last Price 5.59
52-Week Low 4.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar